세계의 세포배양 하이드로겔 시장 : 하이드로겔 유형별, 용도별, 최종사용자별 - 기회 분석과 산업 예측(2024-2035년)

Cell Culture Hydrogel Market By Type of Hydrogel, By Application, By End User : Global Opportunity Analysis and Industry Forecast, 2024-2035

US $ 4,425 ￦ 6,402,000

PDF (Business License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄는 5회 가능하며, 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다. 2명 이상이 이용할 경우, 추가 요금을 지불하여 라이선스 업그레이드로 최대 5명까지 이용 가능합니다.

US $ 7,412 ￦ 10,724,000

PDF (Enterprise User License) & Excel (Data Pack) & Free Update

PDF 보고서 및 Excel 데이터를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다. 보고서 업데이트 서비스가 무료로 제공됩니다.

한글목차

세계의 세포배양 하이드로겔 시장 규모는 2023년에는 4억 달러로 평가되며, 2024-2035년의 CAGR은 15.0%를 보이며, 2035년에는 21억 3,670만 달러에 달할 것으로 추정되고 있습니다.

세포배양 하이드로겔은 시험관내 세포배양을 위한 세포 외 기질(ECM) 환경을 모방하도록 설계된 3차원의 수분이 풍부한 고분자 물질입니다. 이러한 하이드로겔은 세포 기능, 증식 및 분화 유지에 필수적인 구조적 지지, 생화학적 단서 및 기계적 특성을 제공합니다. 하이드로겔은 조직공학, 재생의학, 신약개발과 같은 생의학 연구에 일반적으로 사용됩니다.

줄기세포 치료 및 연구에 대한 관심이 높아지면서 하이드로겔에 대한 수요가 증가하고 있으며, 하이드로겔은 천연 세포 환경을 모방하여 줄기세포의 성장과 분화를 지원합니다. 또한 약물 스크리닝, 오가노이드 개발, 재생 의료를 위한 2D 세포배양에서 3D 세포배양으로의 전환은 하이드로겔에 대한 수요를 크게 증가시키고 있습니다. 연구에 따르면 기계적 특성을 조절할 수 있는 합성 하이드로겔로 지지된 오가노이드 배양은 기존의 매트릭스 스캐폴더에 비해 재현성이 향상되고, 장기와 같은 구조를 보다 정확하게 모방할 수 있는 것으로 나타났습니다. 또한 신약개발 및 약물 개발에 대한 적용이 시장 개척의 원동력이 되고 있습니다. 이는 하이드로겔이 고처리량 약물 스크리닝을 위한 3D 모델 개발을 가능하게 하고, 제약 및 생명공학 산업에서 채택을 촉진할 수 있다는 사실에 기인합니다. 또한 암, 심혈관 질환, 당뇨병과 같은 만성질환을 연구하기 위한 첨단 체외 모델에 대한 요구가 증가함에 따라 생의학 연구에서 하이드로겔에 대한 수요가 증가하고 있습니다. 세계보건기구(WHO)가 발표한 2023년 조사에 따르면 만성질환으로 인해 매년 약 4,100만 명이 사망하는 것으로 나타났습니다. 조직의 미세 환경을 시뮬레이션하기 위해 하이드로겔을 내장하는 경우가 많은 장기 칩 기술의 채택이 증가하면서 시장을 더욱 촉진하고 있습니다. 그러나 경도, 다공성, 분해 속도와 같은 하이드로겔 특성을 특정 용도에 맞게 조정하기 위해서는 기술적 전문 지식과 시간이 필요하며, 이는 시장 성장의 장벽으로 작용하고 있습니다. 또한 마이크로캐리어를 이용한 세포배양이나 스페로이드와 같은 비계를 사용하지 않는 방법과 같은 대안적인 3D 배양법이 이용 가능하다는 점도 시장 성장에 걸림돌이 될 수 있습니다. 반면, 조절 가능한 특성 및 자극 반응성 거동을 가진 스마트 하이드로겔과 같은 하이드로겔 제제의 기술 혁신은 하이드로겔 제제의 기능성과 응용을 확장하고 있습니다. 조직공학 및 재생의료 분야의 연구 및 임상적 노력 증가는 기능성 조직 구조물을 만들기 위한 주요 생체 재료로 작용하는 하이드로겔에 대한 수요를 증가시키고 있습니다. 이러한 발전은 예측 기간 중 세계 시장 확대에 유리한 기회를 제공할 것으로 예상됩니다.

세포배양 하이드로겔 시장은 하이드로겔 유형, 용도, 최종사용자, 지역으로 분류됩니다. 하이드로겔 유형에 따라 시장은 천연 하이드로겔, 합성 하이드로겔, 하이브리드 하이드로겔로 분류됩니다. 용도별로는 암 및 줄기세포 연구, 조직공학 및 재생의료, 신약개발 및 독성시험, 기타로 구분됩니다. 최종사용자별로는 제약/바이오텍 기업, CRO, 연구기관, 기타로 구분됩니다. 지역별로는 북미(미국, 캐나다, 멕시코), 유럽(독일, 프랑스, 영국, 이탈리아, 스페인, 기타), 아시아태평양(일본, 중국, 인도, 호주, 한국, 기타), 라틴아메리카-중동 및 아프리카(브라질, 남아프리카, 사우디아라비아, 기타)로 구분하여 분석합니다. 분석했습니다.

주요 조사 결과

하이드로겔 유형별로는 합성 하이드로겔 부문이 2023년 점유율을 차지할 것으로 예상되며, 2024-2035년 가장 높은 CAGR을 나타낼 것으로 예상됩니다.

용도별로는 조직공학 및 재생의료 부문이 2023년 가장 큰 점유율을 차지했으나, 예측 기간 중 암 및 줄기세포 연구 부문이 가장 높은 CAGR로 성장할 것으로 예상됩니다.

최종사용자별로는 제약 및 생명공학 기업 부문이 2023년 주요 부문이었으나, 예측 기간 중 CRO 부문이 가장 높은 CAGR을 보일 것으로 예상됩니다.

지역별로는 북미가 2023년 세계 세포배양 하이드로겔 시장에서 가장 규모가 큰 지역이었으나, 예측 기간 중 아시아태평양이 가장 높은 CAGR을 나타낼 것으로 예상됩니다.

경쟁사 분석

이해관계자를 위한 주요 이점

이 보고서는 2023-2035년 세포배양 하이드로겔 시장 분석 시장 부문, 현재 동향, 추정 및 분석, 역학을 정량적으로 분석하고 2023-2035년 세포배양 하이드로겔 시장 분석 시장 부문, 현재 동향, 추정 및 분석, 역학을 정량적으로 분석하여 세포배양 하이드로겔 시장의 유력한 기회를 파악합니다.

시장 성장 촉진요인, 시장 성장 억제요인, 시장 기회와 관련된 정보와 함께 시장 조사를 제공합니다.

Porter's Five Forces 분석은 이해 관계자가 이익 중심의 비즈니스 결정을 내리고 공급자와 구매자 네트워크를 강화할 수 있도록 구매자와 공급자의 잠재력을 밝혀냅니다.

세포배양 하이드로겔 시장의 세분화에 대한 상세한 분석은 시장 기회를 결정하는 데 도움이 됩니다.

각 지역의 주요 국가는 세계 시장에 대한 매출 기여도에 따라 매핑되어 있습니다.

시장 기업의 포지셔닝은 벤치마킹을 용이하게 하고, 시장 기업의 현재 위치를 명확하게 이해할 수 있습니다.

세계 세포배양 하이드로겔(Cell Culture Hydrogel) 시장 동향, 주요 기업, 시장 부문, 용도, 시장 성장 전략에 대해 조사 분석을 전해드립니다.

이 보고서에서 가능한 보고서 커스터마이징(추가 비용 및 일정에 대해는 영업 담당자에게 문의)

• 제품별/부문별 기업 시장 점유율 분석
• 주요 기업의 신제품 개발/제품 매트릭스
• 고객의 관심사에 따른 추가 기업 개요
• 기업 개요 확장 리스트
• 과거 시장 데이터

목차

제1장 서론

제2장 개요

제3장 시장 개요

• 시장의 정의와 범위
• 주요 조사 결과
  • 영향요인
  • 주요 투자 기회
• Porter's Five Forces 분석
• 시장 역학
  • 촉진요인
    • Drug Discovery 및 독성 시험에 대한 응용
    • 만성질환과 고령자 인구의 증가
    • 3D 세포배양의 수요 증가
  • 억제요인
    • 숙련 노동력의 부족
  • 기회
    • 신흥 시장에서 높은 성장 가능성
    • 바이오테크놀러지와 생명과학의 진보

제4장 세포배양 하이드로겔 시장 : 하이드로겔 유형별

• 개요
• 천연 하이드로겔
• 합성 하이드로겔
• 하이브리드 하이드로겔

제5장 세포배양 하이드로겔 시장 : 용도별

• 개요
• 암·줄기세포 연구
• 조직공학·재생의료
• Drug Discovery·독성 시험
• 기타

제6장 세포배양 하이드로겔 시장 : 최종사용자별

• 개요
• 제약·바이오테크놀러지 기업
• CRO
• 연구기관
• 기타

제7장 세포배양 하이드로겔 시장 : 지역별

• 개요
• 북미
  • 미국
  • 캐나다
  • 멕시코
• 유럽
  • 독일
  • 프랑스
  • 영국
  • 이탈리아
  • 스페인
  • 기타
• 아시아태평양
  • 일본
  • 중국
  • 호주
  • 인도
  • 한국
  • 기타
• 라틴아메리카·중동 및 아프리카
  • 브라질
  • 사우디아라비아
  • 남아프리카공화국
  • 기타

제8장 경쟁 구도

• 서론
• 주요 성공 전략
• 주요 10사의 제품 지도제작
• 경쟁 대시보드
• 경쟁 히트맵
• 주요 기업의 포지셔닝(2023년)

제9장 기업 개요

• Corning Incorporated
• Merck KGaA
• Humabiologics, Inc
• BICO
• TheWell Bioscience Inc.
• CD Bioparticles
• PELOBIOTECH GmbH
• Cell Guidance Systems
• UPM
• Cellendes GmbH

KSA

영문 목차

영문목차

The cell culture hydrogel market was valued at $400.0 million in 2023 and is estimated to reach $2,136.7 million by 2035, exhibiting a CAGR of 15.0% from 2024 to 2035.

Cell culture hydrogel is a three-dimensional, water-rich polymeric materials designed to mimic the extracellular matrix (ECM) environment for culturing cells in vitro. These hydrogels provide structural support, biochemical cues, and mechanical properties essential for maintaining cellular function, proliferation, and differentiation. They are commonly used in biomedical research, including tissue engineering, regenerative medicine, and drug discovery.

Increase in focus on stem cell therapies and research is a key factors that has fueled the demand for hydrogels, which support stem cell growth and differentiation by mimicking natural cellular environments. In addition, the transition from 2D to 3D cell cultures for drug screening, organoid development, and regenerative medicine has significantly increased the demand for hydrogels. Studies have shown that organoid cultures supported by synthetic hydrogels with tunable mechanical properties enhance reproducibility and mimic organ-like structures more accurately compared to traditional Matrigel scaffolds. Moreover, rising applications in drug discovery and development fuel the growth of the market. This is attributed to the fact that hydrogels enable the development of 3D models for high-throughput drug screening, enhancing their adoption by pharmaceutical and biotechnology industries. Furthermore, rise in need for advanced in vitro models to study chronic diseases like cancer, cardiovascular conditions, and diabetes is fueling the demand for hydrogels in biomedical research. A 2023 study published by the World Health Organization revealed that approximately 41 million individuals die each year due to chronic diseases. Rise in adoption of organ-on-a-chip technologies, which often incorporate hydrogels to simulate tissue microenvironments, further propels the market. However, requirement for tailoring hydrogel properties, such as stiffness, porosity, and degradation rate, to suit specific applications demands technical expertise and time, which acts as a barrier for the market growth. Moreover, availability of alternative 3D culture methods such as microcarrier-based cell cultures or scaffold-free methods like spheroids, can pose challenges to the market growth. On the contrary, innovations in hydrogel formulations, such as smart hydrogels with tunable properties and stimuli-responsive behavior, are expanding their functionality and applications. Rise in research and clinical efforts in tissue engineering and regenerative medicine are boosting the demand for hydrogels, which serve as key biomaterials for creating functional tissue constructs. Such developments are expected to offer lucrative opportunities for the expansion of the global market during the forecast period.

The cell culture hydrogel market is segmented into type of hydrogel, application, end user, and region. By type of hydrogel, the market is segmented into natural hydrogels, synthetic hydrogels, hybrid hydrogels. By application, the market is segmented into cancer and stem cell research, tissue engineering and regenerative medicine, drug discovery and toxicology testing, and others. By end user, the market is segregated into pharmaceutical and biotechnology companies, CROs, research institution, and others. Region wise, the market is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, India, Australia, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and Rest of LAMEA).

Key Findings

Depending on type of hydrogel, the synthetic hydrogels segment dominated the share, in terms of share, in 2023, and is expected to register the highest CAGR from 2024 to 2035.

On the basis of application, the tissue engineering & regenerative medicine segment garnered the largest share in 2023; however, the cancer & stem cell research segment is expected to grow at the highest CAGR during the forecast period.

By end user, the pharmaceutical and biotechnology companies segment was the major shareholder in 2023; however, the CROs segment is anticipated to exhibit the highest CAGR during the forecast period.

Region wise, North America was the largest shareholder in the global cell culture hydrogel market in 2023; however, Asia-Pacific is anticipated to register the highest CAGR during the forecast period.

Competitive Analysis

The key players that operate in the global cell culture hydrogel market are Corning Incorporated, Merck KGaA, Humabiologics, Inc, Cell Guidance Systems, TheWell Bioscience Inc., CD Bioparticles, BICO, PELOBIOTECH GmbH, UPM, and Cellendes GmbH. These players have adopted expansion, agreement, partnership, and collaboration as their key strategies to strengthen their foothold in the global market

Key Benefits for Stakeholders

This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the cell culture hydrogel market analysis from 2023 to 2035 to identify the prevailing cell culture hydrogel market opportunities.

The market research is offered along with information related to key drivers, restraints, and opportunities.

Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.

In-depth analysis of the cell culture hydrogel market segmentation assists to determine the prevailing market opportunities.

Major countries in each region are mapped according to their revenue contribution to the global market.

Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.

The report includes the analysis of the regional as well as global cell culture hydrogel market trends, key players, market segments, application areas, and market growth strategies.

Additional benefits you will get with this purchase are:

• Quarterly Update and* (only available with a corporate license, on listed price)
• 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
• Free Upcoming Version on the Purchase of Five and Enterprise User License.
• 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
• 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
• Free data Pack on the Five and Enterprise User License. (Excel version of the report)
• Free Updated report if the report is 6-12 months old or older.
• 24-hour priority response*
• Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

• Market share analysis of players by products/segments
• New Product Development/ Product Matrix of Key Players
• Additional company profiles with specific to client's interest
• Expanded list for Company Profiles
• Historic market data

Key Market Segments

By Type of Hydrogel

• Synthetic Hydrogels
• Hybrid Hydrogels
• Natural Hydrogels

By Application

• Cancer and Stem Cell Research
• Tissue Engineering and Regenerative Medicine
• Drug Discovery and Toxicology Testing
• Others

By End User

• Research Institutions
• Others
• Pharmaceutical and Biotechnology Companies
• CROs

By Region

• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
• Asia-Pacific
  • Japan
  • China
  • Australia
  • India
  • South Korea
  • Rest of Asia-Pacific
• LAMEA
  • Brazil
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA

Key Market Players:

• Corning Incorporated
• Merck KGaA
• Humabiologics, Inc
• UPM
• PELOBIOTECH GmbH
• CD Bioparticles
• Cell Guidance Systems
• BICO
• TheWell Bioscience Inc.
• Cellendes GmbH

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

• 1.1. Report description
• 1.2. Key market segments
• 1.3. Key benefits to the stakeholders
• 1.4. Research methodology
  • 1.4.1. Primary research
  • 1.4.2. Secondary research
  • 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

• 2.1. CXO perspective

CHAPTER 3: MARKET OVERVIEW

• 3.1. Market definition and scope
• 3.2. Key findings
  • 3.2.1. Top impacting factors
  • 3.2.2. Top investment pockets
• 3.3. Porter's five forces analysis
  • 3.3.1. Moderate bargaining power of suppliers
  • 3.3.2. Moderate threat of new entrants
  • 3.3.3. Moderate threat of substitutes
  • 3.3.4. Moderate intensity of rivalry
  • 3.3.5. Moderate bargaining power of buyers
• 3.4. Market dynamics
  • 3.4.1. Drivers
    • 3.4.1.1. Applications in drug discovery and toxicology testing
    • 3.4.1.2. Rise in prevalence of chronic diseases and aging population
    • 3.4.1.3. Rise in demand for 3D cell culture
  • 3.4.2. Restraints
    • 3.4.2.1. Lack of a skilled workforce
  • 3.4.3. Opportunities
    • 3.4.3.1. High growth potential in emerging markets
    • 3.4.3.2. Advancements in biotechnology and life sciences

CHAPTER 4: CELL CULTURE HYDROGEL MARKET, BY TYPE OF HYDROGEL

• 4.1. Overview
  • 4.1.1. Market size and forecast
• 4.2. Natural Hydrogels
  • 4.2.1. Key market trends, growth factors and opportunities
  • 4.2.2. Market size and forecast, by region
  • 4.2.3. Market share analysis by country
• 4.3. Synthetic Hydrogels
  • 4.3.1. Key market trends, growth factors and opportunities
  • 4.3.2. Market size and forecast, by region
  • 4.3.3. Market share analysis by country
• 4.4. Hybrid Hydrogels
  • 4.4.1. Key market trends, growth factors and opportunities
  • 4.4.2. Market size and forecast, by region
  • 4.4.3. Market share analysis by country

CHAPTER 5: CELL CULTURE HYDROGEL MARKET, BY APPLICATION

• 5.1. Overview
  • 5.1.1. Market size and forecast
• 5.2. Cancer and Stem Cell Research
  • 5.2.1. Key market trends, growth factors and opportunities
  • 5.2.2. Market size and forecast, by region
  • 5.2.3. Market share analysis by country
• 5.3. Tissue Engineering and Regenerative Medicine
  • 5.3.1. Key market trends, growth factors and opportunities
  • 5.3.2. Market size and forecast, by region
  • 5.3.3. Market share analysis by country
• 5.4. Drug Discovery and Toxicology Testing
  • 5.4.1. Key market trends, growth factors and opportunities
  • 5.4.2. Market size and forecast, by region
  • 5.4.3. Market share analysis by country
• 5.5. Others
  • 5.5.1. Key market trends, growth factors and opportunities
  • 5.5.2. Market size and forecast, by region
  • 5.5.3. Market share analysis by country

CHAPTER 6: CELL CULTURE HYDROGEL MARKET, BY END USER

• 6.1. Overview
  • 6.1.1. Market size and forecast
• 6.2. Pharmaceutical and Biotechnology Companies
  • 6.2.1. Key market trends, growth factors and opportunities
  • 6.2.2. Market size and forecast, by region
  • 6.2.3. Market share analysis by country
• 6.3. CROs
  • 6.3.1. Key market trends, growth factors and opportunities
  • 6.3.2. Market size and forecast, by region
  • 6.3.3. Market share analysis by country
• 6.4. Research Institutions
  • 6.4.1. Key market trends, growth factors and opportunities
  • 6.4.2. Market size and forecast, by region
  • 6.4.3. Market share analysis by country
• 6.5. Others
  • 6.5.1. Key market trends, growth factors and opportunities
  • 6.5.2. Market size and forecast, by region
  • 6.5.3. Market share analysis by country

CHAPTER 7: CELL CULTURE HYDROGEL MARKET, BY REGION

• 7.1. Overview
  • 7.1.1. Market size and forecast By Region
• 7.2. North America
  • 7.2.1. Key market trends, growth factors and opportunities
  • 7.2.2. Market size and forecast, by Type of Hydrogel
  • 7.2.3. Market size and forecast, by Application
  • 7.2.4. Market size and forecast, by End User
  • 7.2.5. Market size and forecast, by country
    • 7.2.5.1. U.S.
    • 7.2.5.1.1. Market size and forecast, by Type of Hydrogel
    • 7.2.5.1.2. Market size and forecast, by Application
    • 7.2.5.1.3. Market size and forecast, by End User
    • 7.2.5.2. Canada
    • 7.2.5.2.1. Market size and forecast, by Type of Hydrogel
    • 7.2.5.2.2. Market size and forecast, by Application
    • 7.2.5.2.3. Market size and forecast, by End User
    • 7.2.5.3. Mexico
    • 7.2.5.3.1. Market size and forecast, by Type of Hydrogel
    • 7.2.5.3.2. Market size and forecast, by Application
    • 7.2.5.3.3. Market size and forecast, by End User
• 7.3. Europe
  • 7.3.1. Key market trends, growth factors and opportunities
  • 7.3.2. Market size and forecast, by Type of Hydrogel
  • 7.3.3. Market size and forecast, by Application
  • 7.3.4. Market size and forecast, by End User
  • 7.3.5. Market size and forecast, by country
    • 7.3.5.1. Germany
    • 7.3.5.1.1. Market size and forecast, by Type of Hydrogel
    • 7.3.5.1.2. Market size and forecast, by Application
    • 7.3.5.1.3. Market size and forecast, by End User
    • 7.3.5.2. France
    • 7.3.5.2.1. Market size and forecast, by Type of Hydrogel
    • 7.3.5.2.2. Market size and forecast, by Application
    • 7.3.5.2.3. Market size and forecast, by End User
    • 7.3.5.3. UK
    • 7.3.5.3.1. Market size and forecast, by Type of Hydrogel
    • 7.3.5.3.2. Market size and forecast, by Application
    • 7.3.5.3.3. Market size and forecast, by End User
    • 7.3.5.4. Italy
    • 7.3.5.4.1. Market size and forecast, by Type of Hydrogel
    • 7.3.5.4.2. Market size and forecast, by Application
    • 7.3.5.4.3. Market size and forecast, by End User
    • 7.3.5.5. Spain
    • 7.3.5.5.1. Market size and forecast, by Type of Hydrogel
    • 7.3.5.5.2. Market size and forecast, by Application
    • 7.3.5.5.3. Market size and forecast, by End User
    • 7.3.5.6. Rest of Europe
    • 7.3.5.6.1. Market size and forecast, by Type of Hydrogel
    • 7.3.5.6.2. Market size and forecast, by Application
    • 7.3.5.6.3. Market size and forecast, by End User
• 7.4. Asia-Pacific
  • 7.4.1. Key market trends, growth factors and opportunities
  • 7.4.2. Market size and forecast, by Type of Hydrogel
  • 7.4.3. Market size and forecast, by Application
  • 7.4.4. Market size and forecast, by End User
  • 7.4.5. Market size and forecast, by country
    • 7.4.5.1. Japan
    • 7.4.5.1.1. Market size and forecast, by Type of Hydrogel
    • 7.4.5.1.2. Market size and forecast, by Application
    • 7.4.5.1.3. Market size and forecast, by End User
    • 7.4.5.2. China
    • 7.4.5.2.1. Market size and forecast, by Type of Hydrogel
    • 7.4.5.2.2. Market size and forecast, by Application
    • 7.4.5.2.3. Market size and forecast, by End User
    • 7.4.5.3. Australia
    • 7.4.5.3.1. Market size and forecast, by Type of Hydrogel
    • 7.4.5.3.2. Market size and forecast, by Application
    • 7.4.5.3.3. Market size and forecast, by End User
    • 7.4.5.4. India
    • 7.4.5.4.1. Market size and forecast, by Type of Hydrogel
    • 7.4.5.4.2. Market size and forecast, by Application
    • 7.4.5.4.3. Market size and forecast, by End User
    • 7.4.5.5. South Korea
    • 7.4.5.5.1. Market size and forecast, by Type of Hydrogel
    • 7.4.5.5.2. Market size and forecast, by Application
    • 7.4.5.5.3. Market size and forecast, by End User
    • 7.4.5.6. Rest of Asia-Pacific
    • 7.4.5.6.1. Market size and forecast, by Type of Hydrogel
    • 7.4.5.6.2. Market size and forecast, by Application
    • 7.4.5.6.3. Market size and forecast, by End User
• 7.5. LAMEA
  • 7.5.1. Key market trends, growth factors and opportunities
  • 7.5.2. Market size and forecast, by Type of Hydrogel
  • 7.5.3. Market size and forecast, by Application
  • 7.5.4. Market size and forecast, by End User
  • 7.5.5. Market size and forecast, by country
    • 7.5.5.1. Brazil
    • 7.5.5.1.1. Market size and forecast, by Type of Hydrogel
    • 7.5.5.1.2. Market size and forecast, by Application
    • 7.5.5.1.3. Market size and forecast, by End User
    • 7.5.5.2. Saudi Arabia
    • 7.5.5.2.1. Market size and forecast, by Type of Hydrogel
    • 7.5.5.2.2. Market size and forecast, by Application
    • 7.5.5.2.3. Market size and forecast, by End User
    • 7.5.5.3. South Africa
    • 7.5.5.3.1. Market size and forecast, by Type of Hydrogel
    • 7.5.5.3.2. Market size and forecast, by Application
    • 7.5.5.3.3. Market size and forecast, by End User
    • 7.5.5.4. Rest of LAMEA
    • 7.5.5.4.1. Market size and forecast, by Type of Hydrogel
    • 7.5.5.4.2. Market size and forecast, by Application
    • 7.5.5.4.3. Market size and forecast, by End User

CHAPTER 8: COMPETITIVE LANDSCAPE

• 8.1. Introduction
• 8.2. Top winning strategies
• 8.3. Product mapping of top 10 player
• 8.4. Competitive dashboard
• 8.5. Competitive heatmap
• 8.6. Top player positioning, 2023

CHAPTER 9: COMPANY PROFILES

• 9.1. Corning Incorporated
  • 9.1.1. Company overview
  • 9.1.2. Key executives
  • 9.1.3. Company snapshot
  • 9.1.4. Operating business segments
  • 9.1.5. Product portfolio
  • 9.1.6. Business performance
• 9.2. Merck KGaA
  • 9.2.1. Company overview
  • 9.2.2. Key executives
  • 9.2.3. Company snapshot
  • 9.2.4. Operating business segments
  • 9.2.5. Product portfolio
  • 9.2.6. Business performance
  • 9.2.7. Key strategic moves and developments
• 9.3. Humabiologics, Inc
  • 9.3.1. Company overview
  • 9.3.2. Key executives
  • 9.3.3. Company snapshot
  • 9.3.4. Operating business segments
  • 9.3.5. Product portfolio
  • 9.3.6. Key strategic moves and developments
• 9.4. BICO
  • 9.4.1. Company overview
  • 9.4.2. Key executives
  • 9.4.3. Company snapshot
  • 9.4.4. Operating business segments
  • 9.4.5. Product portfolio
  • 9.4.6. Business performance
• 9.5. TheWell Bioscience Inc.
  • 9.5.1. Company overview
  • 9.5.2. Key executives
  • 9.5.3. Company snapshot
  • 9.5.4. Operating business segments
  • 9.5.5. Product portfolio
  • 9.5.6. Key strategic moves and developments
• 9.6. CD Bioparticles
  • 9.6.1. Company overview
  • 9.6.2. Key executives
  • 9.6.3. Company snapshot
  • 9.6.4. Operating business segments
  • 9.6.5. Product portfolio
• 9.7. PELOBIOTECH GmbH
  • 9.7.1. Company overview
  • 9.7.2. Key executives
  • 9.7.3. Company snapshot
  • 9.7.4. Operating business segments
  • 9.7.5. Product portfolio
• 9.8. Cell Guidance Systems
  • 9.8.1. Company overview
  • 9.8.2. Key executives
  • 9.8.3. Company snapshot
  • 9.8.4. Operating business segments
  • 9.8.5. Product portfolio
• 9.9. UPM
  • 9.9.1. Company overview
  • 9.9.2. Key executives
  • 9.9.3. Company snapshot
  • 9.9.4. Operating business segments
  • 9.9.5. Product portfolio
  • 9.9.6. Business performance
  • 9.9.7. Key strategic moves and developments
• 9.10. Cellendes GmbH
  • 9.10.1. Company overview
  • 9.10.2. Key executives
  • 9.10.3. Company snapshot
  • 9.10.4. Operating business segments
  • 9.10.5. Product portfolio

관련자료